Institution profile

医療法人社団下田緑眞会 世田谷北部病院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2512022 +2

Location

Prefecture
Tokyo
Address
世田谷区南烏山2丁目9-17

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会

Public score

56.2/ 100

A · Review level
25.0 / 30
B · Technologies
15.9 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 56.2
Public score →100

Registered technologies (3)

Stem cells (all sources) 1
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来の培養間葉系間質細胞と自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsPRP and platelet-derivedJoints and musculoskeletalClass II
Adipose-derived stem cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来の培養間葉系間質細胞と自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsPRP and platelet-derivedJoints and musculoskeletalClass II
PRP and platelet-derived 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家脂肪組織由来の培養間葉系間質細胞と自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsPRP and platelet-derivedJoints and musculoskeletalClass II
腱、筋、靭帯等、関節腔外の筋骨格支持組織に対するPRP治療PRP and platelet-derivedJoints and musculoskeletalClass III
Joints and musculoskeletal 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家脂肪組織由来の培養間葉系間質細胞と自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsPRP and platelet-derivedJoints and musculoskeletalClass II
腱、筋、靭帯等、関節腔外の筋骨格支持組織に対するPRP治療PRP and platelet-derivedJoints and musculoskeletalClass III

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会

Public document number

  • 02C2512022
  • 02C2512024
  • 02C2512023
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Class IIJSCSF再生医療等委員会02C2512022
自家脂肪組織由来の培養間葉系間質細胞と自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた関節疾患の治療Class IIJSCSF再生医療等委員会02C2512024
腱、筋、靭帯等、関節腔外の筋骨格支持組織に対するPRP治療Class IIIJSCSF再生医療等委員会02C2512023

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor